Richard Barry - Net Worth and Insider Trading

Richard Barry Net Worth

The estimated net worth of Richard Barry is at least $412 Million dollars as of 2024-12-01. Richard Barry is the Director of Sarepta Therapeutics Inc and owns about 3,079,842 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $411 Million. Richard Barry is the Director of Cassava Sciences Inc and owns about 293,477 shares of Cassava Sciences Inc (SAVA) stock worth over $1 Million. Richard Barry is also the 10% Owner of MabVax Therapeutics Holdings Inc and owns about 1,373 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $32. Details can be seen in Richard Barry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Barry has not made any transactions after 2023-11-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Barry

To

Richard Barry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Barry owns 4 companies in total, including Sarepta Therapeutics Inc (SRPT) , MiMedx Group Inc (MDXG) , and MabVax Therapeutics Holdings Inc (MBVXQ) among others .

Click here to see the complete history of Richard Barry’s form 4 insider trades.

Insider Ownership Summary of Richard Barry

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2023-11-03 director
MDXG MiMedx Group Inc 2019-06-19 director
MBVXQ MabVax Therapeutics Holdings Inc 2012-12-17 10 percent owner
LIMIT LIMIT 2023-08-22 director

Richard Barry Latest Holdings Summary

Richard Barry currently owns a total of 3 stocks. Among these stocks, Richard Barry owns 3,079,842 shares of Sarepta Therapeutics Inc (SRPT) as of November 3, 2023, with a value of $411 Million and a weighting of 99.73%. Richard Barry owns 293,477 shares of Cassava Sciences Inc (SAVA) as of August 22, 2023, with a value of $1 Million and a weighting of 0.27%. Richard Barry also owns 1,373 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of December 17, 2012, with a value of $32 and a weighting of 0%.

Latest Holdings of Richard Barry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2023-11-03 3,079,842 133.34 410,666,132
SAVA Cassava Sciences Inc 2023-08-22 293,477 3.84 1,126,952
MBVXQ MabVax Therapeutics Holdings Inc 2012-12-17 1,373 0.02 32

Holding Weightings of Richard Barry


Richard Barry Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Barry has made a total of 3 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 50,000 shares on November 3, 2023, which cost Richard Barry around $4 Million.

According to the SEC Form 4 filings, Richard Barry has made a total of 3 transactions in Cassava Sciences Inc (SAVA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cassava Sciences Inc is the acquisition of 18,477 shares on August 22, 2023, which cost Richard Barry around $308,012.

According to the SEC Form 4 filings, Richard Barry has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the sale of 272 shares on December 17, 2012, which brought Richard Barry around $90,005.

Insider Trading History of Richard Barry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Barry Trading Performance

GuruFocus tracks the stock performance after each of Richard Barry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Barry is 14.99%. GuruFocus also compares Richard Barry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Barry within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard Barry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard Barry

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
7 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.35 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Richard Barry Ownership Network

Ownership Network List of Richard Barry

No Data

Ownership Network Relation of Richard Barry

Insider Network Chart

Richard Barry Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Richard Barry is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Richard Barry made 1 insider transaction in Sarepta Therapeutics Inc (SRPT) with a net purchase of 50,000. Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .

In summary, during the past 3 months, insiders sold 0 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Richard Barry Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Barry. You might contact Richard Barry via mailing address: 285 Margalita Drive, San Rafael Ca 94901.

Discussions on Richard Barry

No discussions yet.